Abemaciclib 200 MG

DRUG2 trials

Sponsors

Stephen Bagley, MD, MSCE, University of Michigan Rogel Cancer Center

Conditions

Oligodendroglioma, AdultProstate Cancer

Phase 2

Abemaciclib in Patients with Oligodendroglioma

Active, not recruitingNCT03969706

Stephen Bagley, MD, MSCEOligodendroglioma, Adult

Start: 2019-05-15End: 2027-05-15Target: 10Updated: 2024-11-18

Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer

WithdrawnNCT04272645

University of Michigan Rogel Cancer CenterProstate Cancer

Start: 2020-10-31End: 2022-10-31Updated: 2020-07-15

Related Papers

A single-arm, phase 2 clinical trial of abemaciclib in adult patients with recurrent grade 3 oligodendroglioma.

Journal of Clinical Oncology2023-06-011 citations

RBTT-05. A SINGLE-ARM, OPEN-LABEL, PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF ABEMACICLIB IN PATIENTS WITH RECURRENT OLIGODENDROGLIOMA: TRIALS IN PROGRESS

Neuro-Oncology2019-11-01